Fundraising Fox

Enable Injections

Cincinnati, US · Delaware corporation · 6 known investors

enableinjections.com

Enable Injections develops and manufactures enFuse, a wearable drug delivery device that delivers large volumes of pharmaceutical and biologic therapeutics subcutaneously for patients with chronic diseases. The company serves healthcare providers, payers, and patients by offering a mechanical hands-free alternative to intravenous treatment.

BiotechHealthtechMedical Devicesin /enable-injections-llc@enableinjection

Founders & leadership

MH
Mike HoovenChairman, President and CEO
JR
John RiceDirector
TF
Timothy FlahertyExecutive Officer
SS
Simone SongDirector
KR
Karen RobardsDirector
RJ
Richard J D'AugustineDirector
NR
Norman R. WeldonDirector

Investors · 6

Competitors · 8

by search overlap
Diabetes Prevention Program82 shared keywords
Dervan et al49 shared keywords
Healthline38 shared keywordsHealthline publishes medically reviewed health and wellness content for general consumers, drawing on a network of medical reviewers. It operates as a consumer health media and information platform.
visit www.bd.com31 shared keywordsBD (Becton, Dickinson and Company) develops medical technology and solutions used across healthcare settings, including devices and products supporting emergency medications and patient care. It serves hospitals, clinicians, and other healthcare providers in the broader medical device and health technology industry.
ResearchGate30 shared keywords
Cleveland Clinic, 202224 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
Ziprecruiter23 shared keywords
Quizlet22 shared keywords

Companies competing with Enable Injections for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$30MraisedJan 2026 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim CollinsDirector
  • Simone SongDirector
  • Richard J. D'AugustineDirector
  • John RiceDirector
  • David KroekelExecutive Officer
  • John DeFordDirector
  • Matt HuddlestonExecutive Officer
  • Timothy FlahertyExecutive Officer
  • Beckie RobertsonDirector
  • Michael D. HoovenExecutive Officer, Director
  • Erik FalkDirector
  • Nigel SheailDirector
  • Vickie CappsDirector
Offering amount
$30M
Amount sold
$30M
Minimum investment
$1
First sale
Dec 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$150MraisedFeb 2022 · 22 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John RiceDirector
  • Timothy FlahertyExecutive Officer
  • Michael D. HoovenExecutive Officer, Director
  • Simone SongDirector
  • Karen RobardsDirector
  • Richard J D'AugustineDirector
  • Norman R. WeldonDirector
Offering amount
$215M
Amount sold
$150M
Minimum investment
$1
Sales commissions
$8.3M
First sale
Jan 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$30.7MraisedOct 2018 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard D'AugustineDirector
  • Timothy FlahertyExecutive Officer
  • Mark A. CollarDirector
  • Michael D. HoovenExecutive Officer, Director
  • Norman WeldonDirector
  • John RiceDirector
  • Daniel von AllmenDirector
  • Simone SongDirector
  • Susan SpiesExecutive Officer
Offering amount
$50M
Amount sold
$30.7M
Minimum investment
$1
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$25MraisedNov 2016 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Susan SpiesExecutive Officer
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
Offering amount
$25M
Amount sold
$25M
First sale
Aug 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$22.9KraisedAug 2016 · 1 investors · Other Health Care
Officers, directors & promoters on the filing
  • Susan SpiesExecutive Officer
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
Offering amount
$22.9K
Amount sold
$22.9K
First sale
Jun 2014
Incorporated
Limited Liability Company, Delaware
Federal exemptions
04
Full filing on SEC EDGAR ↗
$2MraisedAug 2016 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
  • Susan SpiesExecutive Officer
Offering amount
$2M
Amount sold
$2M
Minimum investment
$25K
First sale
May 2012
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5MraisedAug 2016 · 19 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
  • Susan SpiesExecutive Officer
Offering amount
$5M
Amount sold
$5M
First sale
Jun 2016
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$100KofferedAug 2016 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Susan SpiesExecutive Officer
  • Michael HoovenExecutive Officer
  • Timothy FlahertyExecutive Officer
Offering amount
$100K
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.